MedPath

VIBERZI

VIBERZI

Approved
DIN Number

02460904

Drug Class

Human

Market Date

Apr 24, 2017

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02460904
AIG Number0158810002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A07DA06 ELUXADOLINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ELUXADOLINEActive
Strength: 100 MG
Monograph: ELUXADOLINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.